Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sales forecasting
Biotech
GSK tips 12 blockbuster launches to soften HIV patent loss
GSK plans to launch at least 12 major products and deliver more than $48 billion in risk-adjusted sales by 2031.
Nick Paul Taylor
Jan 31, 2024 7:45am
With steep drop in COVID test sales, Qiagen slashes 2021 outlook
Jul 13, 2021 7:05am
Pfizer tips pipeline to add $15B to sales in coming years
Sep 15, 2020 8:45am
Alcon to launch new hydrogel contact lenses in the U.S.
Aug 19, 2019 10:05am
Boston Scientific misses targets despite earnings growth
Apr 24, 2019 11:42am
